POSTERA
PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and helped lead the world's largest open-science drug discovery effort; COVID Moonshot.
POSTERA
Industry:
Artificial Intelligence (AI) Biotechnology Machine Learning Pharmaceutical Therapeutics
Founded:
2019-10-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.postera.ai
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
26.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Domain Not Resolving Google Tag Manager Euro Apple Mobile Web Clips Icon Google Font API Google Maps DNSSEC Sitelinks Search Box
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Metagenomi
Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - PostEra
HOF Capital
HOF Capital investment in Series A - PostEra
Clermont Group
Clermont Group investment in Series A - PostEra
Metaplanet
Metaplanet investment in Series A - PostEra
Breyer Capital
Breyer Capital investment in Series A - PostEra
Lifeforce Capital
Lifeforce Capital investment in Series A - PostEra
Pioneer Fund
Pioneer Fund investment in Series A - PostEra
I2BF Global Ventures
I2BF Global Ventures investment in Series A - PostEra
Martin Chavez
Martin Chavez investment in Series A - PostEra
HOF Capital
HOF Capital investment in Seed Round - PostEra
Official Site Inspections
http://www.postera.ai Semrush global rank: 7.6 M Semrush visits lastest month: 866
- Host name: acd89244c803f7181.awsglobalaccelerator.com
- IP address: 75.2.60.5
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "PostEra"
About - PostEra
PostEra has developed Proton, an end-to-end machine learning platform to close the Design-Make-Test cycle of Medicinal Chemistry. PostEra’s current focus is on the Chemistry of drug …See details»
Team - PostEra
PostEra is building a modern 21st century biopharma. We use Proton, our AI platform for medicinal chemistry, to accelerate the discovery of new medicines for patients. BD: …See details»
PostEra - Crunchbase Company Profile & Funding
PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top …See details»
PostEra - LinkedIn
PostEra and Pfizer have been working together for nearly 5 years. Most of the work has to stay confidential but now and again we're able to share some behind-the-scenes work on how Proton, our AI ...See details»
PostEra 2025 Company Profile: Valuation, Funding
Developer of an AI-driven drug discovery platform designed to accelerate the traditionally manual process of medicinal chemistry. The company offers a machine learning-based system that iteratively refines candidate drugs, …See details»
PostEra - Company Profile
Postera.ai is an AI-first drug discovery company leveraging machine learning to accelerate the development of new medicines for patients. LeadsOnTrees. Pricing Funding API …See details»
PostEra | Organization | Mindmaps
PostEra Organization. PostEra is a biotech company using its advances in machine learning for medicinal chemistry to get more cures to patients. Investors. ACE & Company Breyer Capital …See details»
PostEra Secures $610M in Funding to Revolutionize Drug …
Jan 8, 2025 PostEra, a pioneering company at the forefront of harnessing machine learning for drug discovery, proudly announces the successful closure of a monumental $610 million …See details»
PostEra: Medicinal Chemistry powered by Machine …
PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements …See details»
PostEra - Company Profile - Boring Business Nerd
In May 2022, PostEra announced a $68 million partnership with the National Institutes of Health to develop antiviral therapeutics.; In January 2022, PostEra announced a partnership with Pfizer …See details»
PostEra
PostEra combines the world’s largest chemical databases with our synthesis technology to get you compounds fast. Expedite your drug discovery program using our machine learning …See details»
PostEra - Funding, Financials, Valuation & Investors - Crunchbase
PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to bring more cures to patients ... Experience the new Crunchbase, powered by AI . …See details»
PostEra announces expansion to $610M in their AI drug discovery ...
Jan 7, 2025 PostEra establishes $260M strategic AI Lab partnership with Pfizer and closes $24M in Series A financing PostEra is building a modern 21st century biopharma. We use …See details»
PostEra (USA) Funding: $26.5M - AI startups
Founders: Aaron Morris, Matt Robinson, Alpha Lee. USA | Funding: $26.5M Website: https://postera.ai/ Medicinal Chemistry as a Service powered by Machine LearningSee details»
A community for all users seeking help, or hoping to provide …
A forum for all topics related to PostEra. A forum for all topics related to PostEra. PostEra. Category ... Ask for help, Provide feedback, Request features for postera.ai/manifold. 0. …See details»
PostEra, Medicinal chemistry as a service powered by machine …
Molecular Design. Whether you need to expand your initial hits or optimize your lead compound, we've pioneered tools that will help. Using state-of-the-art algorithms, we design the optimal …See details»
PostEra - Contacts, Employees, Board Members, Advisors & Alumni
PostEra is building a modern 21st century biopharma. ... Experience the new Crunchbase, powered by AI . Experience the new Crunchbase, powered by AI . Organization. PostEra . …See details»
News - PostEra
PostEra is building a modern 21st century biopharma. We use Proton, our AI platform for medicinal chemistry, to accelerate the discovery of new medicines for patients. BD: …See details»
Evolving OpenAI’s structure
6 days ago As AI accelerates, our commitment to safety grows stronger. We want to make sure democratic AI wins over authoritarian AI. We made the decision for the nonprofit to stay in …See details»
The PostEra Pipeline
PostEra is using our Proton platform to develop cures for diseases via an internal drug discovery pipeline and also through co-discovery with pharma partners. ... We use Proton, our AI …See details»